Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Goodwill & Intangibles: 2010-2024

Historic Goodwill & Intangibles for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to $9.6 million.

  • Anika Therapeutics' Goodwill & Intangibles fell 58.70% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year decrease of 58.70%. This contributed to the annual value of $9.6 million for FY2024, which is 64.92% down from last year.
  • Latest data reveals that Anika Therapeutics reported Goodwill & Intangibles of $9.6 million as of FY2024, which was down 64.92% from $27.4 million recorded in FY2023.
  • Anika Therapeutics' 5-year Goodwill & Intangibles high stood at $127.3 million for FY2020, and its period low was $9.6 million during FY2024.
  • Its 3-year average for Goodwill & Intangibles is $52.2 million, with a median of $27.4 million in 2023.
  • Per our database at Business Quant, Anika Therapeutics' Goodwill & Intangibles soared by 254.52% in 2020 and then slumped by 77.06% in 2023.
  • Yearly analysis of 5 years shows Anika Therapeutics' Goodwill & Intangibles stood at $127.3 million in 2020, then dropped by 5.31% to $120.5 million in 2021, then decreased by 0.86% to $119.5 million in 2022, then tumbled by 77.06% to $27.4 million in 2023, then crashed by 64.92% to $9.6 million in 2024.